PATENT CLAIM ANALYSIS

Application Number: 16081904
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-06
Patent Classification: ["514", "064000"]

Abstract:
Compounds, pharmaceutical formulations, and methods of treating bacterial infections are disclosed.

Claim (Index 13):
The compound of  claim 11 , or a salt or a hydrate or a solvate thereof, which is (3aR,4R,5R,7R,8S,9R,9aS,12R)-8-hydroxy-4,7,9,12-tetramethyl-7-((R)-oxiran-2-yl)-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)oxy)acetate.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16081902', '15718422', '15986747', '13606949', '14688581']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6920375048405593
- 35 USC 102 Novelty (BERT): 0.5517896363362494
- Combined Prediction Score: 0.6780127179901283
- Mean Citation Score: 255.67250400000003
- Max Citation Score: 390.4352
- Similarity Product: 314.68467176704405

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test